| Year |
Citation |
Score |
| 2024 |
Wang E, Liu S, Zhang X, Peng Q, Yu H, Gao L, Xie A, Ma D, Zhao G, Cheng L. An Optimized Human Erythroblast Differentiation System Reveals Cholesterol-Dependency of Robust Production of Cultured Red Blood Cells Ex Vivo. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2303471. PMID 38481061 DOI: 10.1002/advs.202303471 |
0.414 |
|
| 2022 |
Zhang S, Qu K, Lyu S, Hoyle DL, Smith C, Cheng L, Cheng T, Shen J, Wang ZZ. PEAR1 is a potential regulator of early hematopoiesis of human pluripotent stem cells. Journal of Cellular Physiology. PMID 36436185 DOI: 10.1002/jcp.30924 |
0.503 |
|
| 2021 |
Deng J, Lancelot M, Jajosky R, Deng Q, Deeb K, Saakadze N, Gao Y, Jaye D, Liu S, Stowell SR, Cheng L, Roback JD. Erythropoietic Properties of Human iPSC-derived RBCs in Immunodeficient Mice. American Journal of Hematology. PMID 34779029 DOI: 10.1002/ajh.26410 |
0.386 |
|
| 2021 |
Kammers K, Taub MA, Mathias RA, Yanek LR, Kanchan K, Venkatraman V, Sundararaman N, Martin J, Liu S, Hoyle D, Raedschelders K, Holewinski R, Parker S, Dardov V, Faraday N, ... ... Cheng L, et al. Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells. Journal of Thrombosis and Haemostasis : Jth. PMID 33829634 DOI: 10.1111/jth.15334 |
0.489 |
|
| 2021 |
Liu S, Wu M, Lancelot M, Deng J, Gao Y, Roback JD, Chen T, Cheng L. BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33484967 DOI: 10.1016/j.ymthe.2021.01.022 |
0.397 |
|
| 2020 |
Das D, Li J, Liu S, Oh E, Cheng L, Lyketsos C, Mahairaki V. Generation and characterization of a novel human iPSC line from a resilient Alzheimer's disease patient. Stem Cell Research. 48: 101979. PMID 32916633 DOI: 10.1016/J.Scr.2020.101979 |
0.481 |
|
| 2020 |
Das D, Li J, Cheng L, Franco S, Mahairaki V. Human Forebrain Organoids from Induced Pluripotent Stem Cells: A Novel Approach to Model Repair of Ionizing Radiation-Induced DNA Damage in Human Neurons. Radiation Research. 194: 191-198. PMID 32845994 DOI: 10.1667/Rr15567.1 |
0.424 |
|
| 2020 |
Morales Pantoja IE, Smith MD, Rajbhandari L, Cheng L, Gao Y, Mahairaki V, Venkatesan A, Calabresi PA, Fitzgerald KC, Whartenby KA. iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu. Plos One. 15: e0233980. PMID 32511247 DOI: 10.1371/Journal.Pone.0233980 |
0.439 |
|
| 2020 |
Kanchan K, Iyer K, Yanek LR, Carcamo-Orive I, Taub MA, Malley C, Baldwin K, Becker LC, Broeckel U, Cheng L, Cowan C, D'Antonio M, Frazer KA, Quertermous T, Mostoslavsky G, et al. Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program. Stem Cell Research. 46: 101803. PMID 32442913 DOI: 10.1016/J.Scr.2020.101803 |
0.441 |
|
| 2020 |
Choi IY, Lim H, Cho HJ, Oh Y, Chou BK, Bai H, Cheng L, Kim YJ, Hyun S, Kim H, Shin JH, Lee G. Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors. Elife. 9. PMID 32011235 DOI: 10.7554/Elife.46981 |
0.508 |
|
| 2019 |
Katt ME, Mayo LN, Ellis SE, Mahairaki V, Rothstein JD, Cheng L, Searson PC. The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model. Fluids and Barriers of the Cns. 16: 20. PMID 31303172 DOI: 10.1186/S12987-019-0139-4 |
0.363 |
|
| 2019 |
Shen J, Zhu Y, Lyu C, Feng Z, Lyu S, Zhao Y, Hoyle DL, Ji G, Miao W, Zhang X, Cheng L, Brodsky RA, Cheng T, Wang ZZ. Sequential cellular niches control the generation of enucleated erythrocytes from human pluripotent stem cells. Haematologica. PMID 31197070 DOI: 10.3324/Haematol.2018.211664 |
0.541 |
|
| 2019 |
Liu S, Mahairaki V, Bai H, Ding Z, Li J, Witwer KW, Cheng L. Highly purified human extracellular vesicles produced by stem cells alleviate aging cellular phenotypes of senescent human cells. Stem Cells (Dayton, Ohio). PMID 30811771 DOI: 10.1002/Stem.2996 |
0.549 |
|
| 2019 |
Wu M, Liu S, Cheng L, Chen T. Elucidating an Essential Role of Promoting Endothelial-to-Hematopoietic Transition By a Key EMT-Regulator ZEB2 Using a Human iPSC-Based Model Blood. 134: 3716-3716. DOI: 10.1182/Blood-2019-126908 |
0.343 |
|
| 2018 |
Linville RM, DeStefano JG, Sklar MB, Xu Z, Farrell AM, Bogorad MI, Chu C, Walczak P, Cheng L, Mahairaki V, Whartenby KA, Calabresi PA, Searson PC. Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior. Biomaterials. 190: 24-37. PMID 30391800 DOI: 10.1016/J.Biomaterials.2018.10.023 |
0.345 |
|
| 2018 |
Li C, Cheng L, Wu H, He P, Zhang Y, Yang Y, Chen J, Chen M. Activation of the KEAP1‑NRF2‑ARE signaling pathway reduces oxidative stress in Hep2 cells. Molecular Medicine Reports. PMID 30015918 DOI: 10.3892/mmr.2018.9288 |
0.375 |
|
| 2018 |
Wei S, Wang J, Oyinlade O, Ma D, Wang S, Kratz L, Lal B, Xu Q, Liu S, Shah SR, Zhang H, Li Y, Quiñones-Hinojosa A, Zhu H, Huang ZY, ... Cheng L, et al. Heterozygous IDH1 created by "single base editing" inhibits human astroglial cell growth by downregulating YAP. Oncogene. PMID 29849122 DOI: 10.1038/S41388-018-0334-9 |
0.362 |
|
| 2018 |
Wu M, Liu S, Gao Y, Bai H, Machairaki V, Li G, Chen T, Cheng L. Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system. Stem Cell Research. 29: 6-14. PMID 29554589 DOI: 10.1016/J.Scr.2018.03.003 |
0.493 |
|
| 2018 |
Alkadi H, McKellar D, Zhen T, Karpova T, Garrett LJ, Gao Y, Alsadhan AA, Kwon EM, Greene JJ, Ball DA, Cheng L, Sorrell AD, Liu PP. The VWRPY Domain Is Essential for RUNX1 Function in Hematopoietic Progenitor Cell Maturation and Megakaryocyte Differentiation Blood. 132: 1319-1319. DOI: 10.1182/Blood-2018-99-113400 |
0.451 |
|
| 2017 |
Cai L, Bai H, Mahairaki V, Gao Y, He C, Wen Y, Jin YC, Wang Y, Pan RL, Qasba A, Ye Z, Cheng L. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease. Stem Cells Translational Medicine. PMID 29164808 DOI: 10.1002/Sctm.17-0066 |
0.711 |
|
| 2017 |
Li Y, Jin C, Bai H, Gao Y, Sun S, Chen L, Qin L, Liu PP, Cheng L, Wang QF. Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation. Blood. PMID 29101237 DOI: 10.1182/Blood-2017-04-780379 |
0.536 |
|
| 2017 |
Yuan X, Li Z, Baines AC, Gavriilaki E, Ye Z, Wen Z, Braunstein EM, Biesecker LG, Cheng L, Dong X, Brodsky RA. A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model. Plos One. 12: e0174074. PMID 28441409 DOI: 10.1371/Journal.Pone.0174074 |
0.685 |
|
| 2017 |
Liu S, Ye Z, Gao Y, He C, Williams DW, Moliterno A, Spivak J, Huang H, Cheng L. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene. Stem Cell Research. 18: 57-59. PMID 28395806 DOI: 10.1016/J.Scr.2016.12.012 |
0.742 |
|
| 2017 |
Yang C, Shang X, Cheng L, Yang L, Liu X, Bai C, Wei Z, Hua J, Li G. DNMT 1 maintains hypermethylation of CAG promoter specific region and prevents expression of exogenous gene in fat-1 transgenic sheep. Plos One. 12: e0171442. PMID 28158319 DOI: 10.1371/journal.pone.0171442 |
0.305 |
|
| 2017 |
Kammers K, Taub MA, Ruczinski I, Martin J, Yanek LR, Frazee A, Gao Y, Hoyle D, Faraday N, Becker DM, Cheng L, Wang ZZ, Leek JT, Becker LC, Mathias RA. Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis. Plos One. 12: e0167794. PMID 28107356 DOI: 10.1371/Journal.Pone.0167794 |
0.481 |
|
| 2016 |
Bhatt N, Ghosh R, Roy S, Gao Y, Armanios M, Cheng L, Franco S. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T). Stem Cell Research. 17: 205-207. PMID 27879207 DOI: 10.1016/J.Scr.2016.08.003 |
0.559 |
|
| 2016 |
Bhatt N, Ghosh R, Roy S, Gao Y, Armanios M, Cheng L, Franco S. Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells. Stem Cell Research. 17: 296-305. PMID 27596957 DOI: 10.1016/J.Scr.2016.08.006 |
0.567 |
|
| 2016 |
Long H, Miller SF, Strauss C, Zhao C, Cheng L, Ye Z, Griffin K, Te R, Lee H, Chen CC, Lynch M. Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 27091991 DOI: 10.1073/Pnas.1601208113 |
0.597 |
|
| 2016 |
Smith C, Ye Z, Cheng L. Genome Editing in Human Pluripotent Stem Cells. Cold Spring Harbor Protocols. 2016: pdb.top086819. PMID 27037079 DOI: 10.1101/Pdb.Top086819 |
0.731 |
|
| 2016 |
Smith C, Ye Z, Cheng L. A Method for Genome Editing in Human Pluripotent Stem Cells. Cold Spring Harbor Protocols. 2016: pdb.prot090217. PMID 27037073 DOI: 10.1101/Pdb.Prot090217 |
0.709 |
|
| 2016 |
Senquan L, Williams DM, Moliterno AR, Spivak JL, Huang H, Gao Y, Ye Z, Cheng L. Generation, Characterization and Genetic Modification of Human iPSCs Containing Calr, MPL and JAK2 Mutations Found in MPN Patients Blood. 128: 3139-3139. DOI: 10.1182/Blood.V128.22.3139.3139 |
0.732 |
|
| 2016 |
Alkadi HI, Karpova TS, Kwon EM, Garrett LJ, Gao Y, Wincovitch S, Alsadhan A, Greene JJ, Ball DA, Cheng L, Sorrell AD, Liu PP. Unraveling a Novel Mechanism of RUNX1 Activity in Familial Platelet Disorder with Associated Myeloid Malignancy Blood. 128: 2693-2693. DOI: 10.1182/Blood.V128.22.2693.2693 |
0.412 |
|
| 2015 |
Bai H, Liu Y, Xie Y, Hoyle DL, Brodsky RA, Cheng L, Cheng T, Wang ZZ. Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated from Hemogenic Endothelial Cells in Human Pluripotent Stem Cells. Journal of Cellular Physiology. PMID 26395760 DOI: 10.1002/Jcp.25199 |
0.533 |
|
| 2015 |
Chou BK, Gu H, Gao Y, Dowey SN, Wang Y, Shi J, Li Y, Ye Z, Cheng T, Cheng L. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Translational Medicine. 4: 320-32. PMID 25742692 DOI: 10.5966/Sctm.2014-0214 |
0.772 |
|
| 2015 |
Liu Y, Wang Y, Gao Y, Forbes JA, Qayyum R, Becker L, Cheng L, Wang ZZ. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents. Stem Cells Translational Medicine. 4: 309-19. PMID 25713465 DOI: 10.5966/Sctm.2014-0183 |
0.532 |
|
| 2015 |
Wang J, Wang N, Jin Y, Si J, Tan ZK, Du H, Cheng L, Dai X, Bai S, He H, Ye Z, Lai ML, Friend RH, Huang W. Interfacial control toward efficient and low-voltage perovskite light-emitting diodes. Advanced Materials (Deerfield Beach, Fla.). 27: 2311-6. PMID 25708283 DOI: 10.1002/Adma.201405217 |
0.528 |
|
| 2015 |
Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J, Gao Y, Mendelsohn L, Cheng L. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation. Stem Cells (Dayton, Ohio). 33: 1470-9. PMID 25702619 DOI: 10.1002/Stem.1969 |
0.766 |
|
| 2015 |
All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou BK, Shah S, Resar LM, Cheng L, Gearhart JD, Kerr CL. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. Plos One. 10: e0116933. PMID 25635918 DOI: 10.1371/Journal.Pone.0116933 |
0.492 |
|
| 2015 |
Smith C, Abalde-Atristain L, He C, Brodsky BR, Braunstein EM, Chaudhari P, Jang YY, Cheng L, Ye Z. Efficient and allele-specific genome editing of disease loci in human iPSCs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 570-7. PMID 25418680 DOI: 10.1038/Mt.2014.226 |
0.697 |
|
| 2015 |
All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou B, Shah S, Resar LM, Cheng L, Gearhart JD, Kerr CL. Bright field microscopy images of the various stages of oligodendrocyte differentiation from induced pluripotent stem cells of the BC1 line. Plos One. DOI: 10.1371/Journal.Pone.0116933.G001 |
0.449 |
|
| 2015 |
Braunstein EM, Li R, Sobreira N, Gocke C, Brodsky RA, Valle D, Cheng L. A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia Blood. 126: 4105-4105. DOI: 10.1182/Blood.V126.23.4105.4105 |
0.385 |
|
| 2015 |
Chou B, Bai H, Gao Y, Wang Y, Ye Z, Kwon EM, Liu PP, Friedman AD, Wang ZZ, Cheng L. The Roles of RUNX1 in Human Hematopoiesis and Megakaryopoiesis Revealed By Genome-Targeted Human iPSCs and an Improved Hematopoietic Differentiation Model Blood. 126: 1167-1167. DOI: 10.1182/Blood.V126.23.1167.1167 |
0.763 |
|
| 2014 |
Cai J, Miao X, Li Y, Smith C, Tsang K, Cheng L, Wang QF. Whole-genome sequencing identifies genetic variances in culture-expanded human mesenchymal stem cells. Stem Cell Reports. 3: 227-33. PMID 25254336 DOI: 10.1016/J.Stemcr.2014.05.019 |
0.432 |
|
| 2014 |
Wen Z, Nguyen HN, Guo Z, Lalli MA, Wang X, Su Y, Kim NS, Yoon KJ, Shin J, Zhang C, Makri G, Nauen D, Yu H, Guzman E, Chiang CH, ... ... Cheng L, et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. 515: 414-8. PMID 25132547 DOI: 10.1038/Nature13716 |
0.351 |
|
| 2014 |
Connelly JP, Kwon EM, Gao Y, Trivedi NS, Elkahloun AG, Horwitz MS, Cheng L, Liu PP. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. Blood. 124: 1926-30. PMID 25114263 DOI: 10.1182/Blood-2014-01-550525 |
0.462 |
|
| 2014 |
Smith C, Gore A, Yan W, Abalde-Atristain L, Li Z, He C, Wang Y, Brodsky RA, Zhang K, Cheng L, Ye Z. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell. 15: 12-3. PMID 24996165 DOI: 10.1016/J.Stem.2014.06.011 |
0.692 |
|
| 2014 |
Huang K, Shen Y, Xue Z, Bibikova M, April C, Liu Z, Cheng L, Nagy A, Pellegrini M, Fan JB, Fan G. A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells. Stem Cell Reports. 2: 36-43. PMID 24511466 DOI: 10.1016/J.Stemcr.2013.11.003 |
0.441 |
|
| 2014 |
Shah S, Huang X, Cheng L. Concise review: stem cell-based approaches to red blood cell production for transfusion. Stem Cells Translational Medicine. 3: 346-55. PMID 24361925 DOI: 10.5966/Sctm.2013-0054 |
0.415 |
|
| 2014 |
Belet S, Fieremans N, Yuan X, Van Esch H, Verbeeck J, Ye Z, Cheng L, Brodsky BR, Hu H, Kalscheuer VM, Brodsky RA, Froyen G. Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality. Human Mutation. 35: 350-5. PMID 24357517 DOI: 10.1002/Humu.22498 |
0.64 |
|
| 2014 |
Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Engineering. Part A. 20: 1295-305. PMID 24279868 DOI: 10.1089/ten.TEA.2013.0211 |
0.4 |
|
| 2014 |
Wang Y, Cheng L, Gerecht S. Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013. Annals of Biomedical Engineering. 42: 1357-72. PMID 24132657 DOI: 10.1007/S10439-013-0921-4 |
0.437 |
|
| 2014 |
Ye Z, Liu CF, Lanikova L, Dowey SN, He C, Huang X, Brodsky RA, Spivak JL, Prchal JT, Cheng L. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 32: 269-78. PMID 24105986 DOI: 10.1002/Stem.1545 |
0.723 |
|
| 2014 |
Huang X, Shah S, Wang J, Ye Z, Dowey SN, Tsang KM, Mendelsohn LG, Kato GJ, Kickler TS, Cheng L. Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 451-63. PMID 24002691 DOI: 10.1038/Mt.2013.201 |
0.739 |
|
| 2014 |
Yu Y, Liang D, Tian Q, Chen X, Jiang B, Chou BK, Hu P, Cheng L, Gao P, Li J, Wang G. Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis. Stem Cells (Dayton, Ohio). 32: 349-63. PMID 23765875 DOI: 10.1002/Stem.1447 |
0.463 |
|
| 2013 |
TheinHan W, Liu J, Tang M, Chen W, Cheng L, Xu HH. Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements. Bone Research. 4: 371-384. PMID 24839581 DOI: 10.4248/BR201304008 |
0.422 |
|
| 2013 |
Yuan X, Braunstein EM, Ye Z, Liu CF, Chen G, Zou J, Cheng L, Brodsky RA. Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells. Stem Cells Translational Medicine. 2: 819-29. PMID 24113066 DOI: 10.5966/Sctm.2013-0069 |
0.787 |
|
| 2013 |
Chou BK, Cheng L. And then there were none: no need for pluripotency factors to induce reprogramming. Cell Stem Cell. 13: 261-2. PMID 24012365 DOI: 10.1016/J.Stem.2013.08.004 |
0.385 |
|
| 2013 |
Wang Y, Chou BK, Dowey S, He C, Gerecht S, Cheng L. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Research. 11: 1103-16. PMID 23973800 DOI: 10.1016/J.Scr.2013.07.011 |
0.488 |
|
| 2013 |
Yan W, Smith C, Cheng L. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing. Scientific Reports. 3: 2376. PMID 23921522 DOI: 10.1038/Srep02376 |
0.37 |
|
| 2013 |
Kusuma S, Shen YI, Hanjaya-Putra D, Mali P, Cheng L, Gerecht S. Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proceedings of the National Academy of Sciences of the United States of America. 110: 12601-6. PMID 23858432 DOI: 10.1073/pnas.1306562110 |
0.651 |
|
| 2013 |
Ran D, Lam K, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells. Blood. 121: 5252-3. PMID 23813938 DOI: 10.1182/Blood-2013-04-494914 |
0.756 |
|
| 2013 |
Chou BK, Ye Z, Cheng L. Generation and homing of iPSC-derived hematopoietic cells in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1292-3. PMID 23812546 DOI: 10.1038/Mt.2013.129 |
0.764 |
|
| 2013 |
Ran D, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells. Blood. 121: 2882-90. PMID 23372166 DOI: 10.1182/Blood-2012-08-451641 |
0.771 |
|
| 2013 |
Kwon EM, Connelly JP, Gao Y, Horwitz M, Cheng L, Liu PP. Targeted correction Of RUNX1 Mutation In The FPD Patient-Specific Induced Pluripotent Stem Cells Restores Megakaryocytic Differentiation Blood. 122: 738-738. DOI: 10.1182/Blood.V122.21.738.738 |
0.506 |
|
| 2013 |
Liu Y, Gao Y, Shah S, Becker L, Cheng L, Wang ZZ. FDA-Approved Pharmacological Agents, Romiplostium and Oprelvekin, Synergistically Promote Megakaryocytic Differentiation From Human iPSCs In a Chemically Defined System Blood. 122: 1208-1208. DOI: 10.1182/Blood.V122.21.1208.1208 |
0.499 |
|
| 2012 |
Wei KL, Yang YJ, Yao YJ, Du LZ, Wang QH, Wang RH, Wang L, Lin Y, Liu J, Wang H, Wang XL, Wu HM, Wu K, Chen Y, Zhong XY, ... ... Cheng LX, et al. Epidemiologic survey on hospitalized neonates in China. Translational Pediatrics. 1: 15-22. PMID 26835259 DOI: 10.3978/j.issn.2224-4336.2011.10.01 |
0.52 |
|
| 2012 |
Dowey SN, Huang X, Chou BK, Ye Z, Cheng L. Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nature Protocols. 7: 2013-21. PMID 23080273 DOI: 10.1038/Nprot.2012.121 |
0.758 |
|
| 2012 |
Ye Z, Chou BK, Cheng L. Promise and challenges of human iPSC-based hematologic disease modeling and treatment. International Journal of Hematology. 95: 601-9. PMID 22619021 DOI: 10.1007/S12185-012-1095-9 |
0.73 |
|
| 2012 |
Khatau SB, Kusuma S, Hanjaya-Putra D, Mali P, Cheng L, Lee JS, Gerecht S, Wirtz D. The differential formation of the LINC-mediated perinuclear actin cap in pluripotent and somatic cells. Plos One. 7: e36689. PMID 22574215 DOI: 10.1371/Journal.Pone.0036689 |
0.691 |
|
| 2012 |
Cheng L, Hansen NF, Zhao L, Du Y, Zou C, Donovan FX, Chou BK, Zhou G, Li S, Dowey SN, Ye Z, Chandrasekharappa SC, Yang H, Mullikin JC, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell. 10: 337-44. PMID 22385660 DOI: 10.1016/J.Stem.2012.01.005 |
0.717 |
|
| 2012 |
Johnston JJ, Gropman AL, Sapp JC, Teer JK, Martin JM, Liu CF, Yuan X, Ye Z, Cheng L, Brodsky RA, Biesecker LG. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. American Journal of Human Genetics. 90: 295-300. PMID 22305531 DOI: 10.1016/J.Ajhg.2011.11.031 |
0.647 |
|
| 2012 |
Zou C, Chou BK, Dowey SN, Tsang K, Huang X, Liu CF, Smith C, Yen J, Mali P, Zhang YA, Cheng L, Ye Z. Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines. Stem Cells and Development. 21: 2298-311. PMID 22225458 DOI: 10.1089/Scd.2011.0688 |
0.832 |
|
| 2012 |
Mali P, Cheng L. Concise review: Human cell engineering: cellular reprogramming and genome editing. Stem Cells (Dayton, Ohio). 30: 75-81. PMID 21905170 DOI: 10.1002/Stem.735 |
0.739 |
|
| 2012 |
Huang X, Shah S, Wang Y, Dowey SN, Ye Z, Cheng L. Extensive Ex Vivo Expansion of Functional Human Erythroid Precursor Cells From Reprogrammed Post-Natal Blood Mononuclear Cells by Defined Factors Blood. 120: 975-975. DOI: 10.1182/Blood.V120.21.975.975 |
0.741 |
|
| 2012 |
Yuan X, Ye Z, Liu CF, Zou J, Cheng L, Brodsky RA. Generation of GPI Anchor Deficient Blood Cells From Human iPSCs. Blood. 120: 2358-2358. DOI: 10.1182/Blood.V120.21.2358.2358 |
0.774 |
|
| 2012 |
Tian L, Piterkova L, Wang L, Ye Z, Cheng L, Wheeler DA, Hakonarson H, Prchal JT. Whole Genome Sequencing of Four CD34+-Derived iPSC Polycythemia Vera Clones From a Single Female Blood. 120: 1755-1755. DOI: 10.1182/Blood.V120.21.1755.1755 |
0.689 |
|
| 2012 |
Chen S, Brennen N, Brodsky RA, Cheng L, Denmeade SR, Isaacs JT. Abstract 5699: Mesenchymal stem cells (MSCs) as a selective delivery vehicle for a PSA-activated protoxin for advanced prostate cancer Cancer Research. 72: 5699-5699. DOI: 10.1158/1538-7445.Am2012-5699 |
0.421 |
|
| 2011 |
Cheng L, Blazar B, High K, Porteus M. Zinc fingers hit off target. Nature Medicine. 17: 1192-3. PMID 21988995 DOI: 10.1038/Nm1011-1192 |
0.312 |
|
| 2011 |
Zou J, Mali P, Huang X, Dowey SN, Cheng L. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood. 118: 4599-608. PMID 21881051 DOI: 10.1182/Blood-2011-02-335554 |
0.69 |
|
| 2011 |
Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, Sharkis S, Ye Z, Jang YY. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent Stem cells Blood. 118: 1801-1805. PMID 21628406 DOI: 10.1182/Blood-2011-03-340620 |
0.741 |
|
| 2011 |
Jang YY, Ye Z, Cheng L. Molecular imaging and stem cell research. Molecular Imaging. 10: 111-22. PMID 21439256 DOI: 10.2310/7290.2010.00046 |
0.74 |
|
| 2011 |
Zou J, Sweeney CL, Chou BK, Choi U, Pan J, Wang H, Dowey SN, Cheng L, Malech HL. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood. 117: 5561-72. PMID 21411759 DOI: 10.1182/Blood-2010-12-328161 |
0.388 |
|
| 2011 |
Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder MC. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood. 117: 4773-7. PMID 21393480 DOI: 10.1182/Blood-2011-01-330514 |
0.754 |
|
| 2011 |
Wang B, Zhang YB, Zhang F, Lin H, Wang X, Wan N, Ye Z, Weng H, Zhang L, Li X, Yan J, Wang P, Wu T, Cheng L, Wang J, et al. On the origin of Tibetans and their genetic basis in adapting high-altitude environments. Plos One. 6: e17002. PMID 21386899 DOI: 10.1371/Journal.Pone.0017002 |
0.566 |
|
| 2011 |
Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LM, Zou C, Zhang YA, Tong J, Cheng L. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Research. 21: 518-29. PMID 21243013 DOI: 10.1038/Cr.2011.12 |
0.828 |
|
| 2011 |
Ye Z, Piterkova L, Liu CF, Dowey SN, Chou B, Huang X, Spivak JL, Swierczek S, Moliterno AR, Prchal JT, Cheng L. Distinct Induced Pluripotent Stem Cell Clones with Somatic Mutations Prepared From PV Patients Blood. 118: 2826-2826. DOI: 10.1182/Blood.V118.21.2826.2826 |
0.756 |
|
| 2010 |
Li D, Zhou J, Wang L, Shin ME, Su P, Lei X, Kuang H, Guo W, Yang H, Cheng L, Tanaka TS, Leckband DE, Reynolds AB, Duan E, Wang F. Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions. The Journal of Cell Biology. 191: 631-44. PMID 20974810 DOI: 10.1083/Jcb.201006094 |
0.348 |
|
| 2010 |
Ohm JE, Mali P, Van Neste L, Berman DM, Liang L, Pandiyan K, Briggs KJ, Zhang W, Argani P, Simons B, Yu W, Matsui W, Van Criekinge W, Rassool FV, Zambidis E, ... ... Cheng L, et al. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Research. 70: 7662-73. PMID 20841480 DOI: 10.1158/0008-5472.Can-10-1361 |
0.736 |
|
| 2010 |
Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells (Dayton, Ohio). 28: 1893-904. PMID 20715183 DOI: 10.1002/Stem.499 |
0.72 |
|
| 2010 |
Ye Z, Cheng L. Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types. Regenerative Medicine. 5: 521-30. PMID 20632856 DOI: 10.2217/Rme.10.38 |
0.781 |
|
| 2010 |
Kerr CL, Cheng L. Multiple, interconvertible states of human pluripotent stem cells. Cell Stem Cell. 6: 497-9. PMID 20569683 DOI: 10.1016/J.Stem.2010.05.014 |
0.567 |
|
| 2010 |
Mali P, Ye Z, Chou BK, Yen J, Cheng L. An improved method for generating and identifying human induced pluripotent stem cells. Methods in Molecular Biology (Clifton, N.J.). 636: 191-205. PMID 20336524 DOI: 10.1007/978-1-60761-691-7_12 |
0.823 |
|
| 2010 |
Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, Brodsky RA, Ohm JE, Yu W, Baylin SB, Yusa K, Bradley A, Meyers DJ, Mukherjee C, Cole PA, ... Cheng L, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (Dayton, Ohio). 28: 713-20. PMID 20201064 DOI: 10.1002/Stem.402 |
0.828 |
|
| 2010 |
Zou J, Cochran R, Cheng L. Double knockouts in human embryonic stem cells. Cell Research. 20: 250-2. PMID 20190774 DOI: 10.1038/Cr.2010.29 |
0.566 |
|
| 2010 |
Kerr CL, Cheng L. The dazzle in germ cell differentiation. Journal of Molecular Cell Biology. 2: 26-9. PMID 20008336 DOI: 10.1093/Jmcb/Mjp041 |
0.564 |
|
| 2010 |
Huang X, Chou B, Mali P, Ye Z, Dowey SN, Cheng L. Human IPS Cells Generated From Adult Peripheral Blood Cells and Purified CD34+ Cells by a Non-Integrating Plasmid. Blood. 116: 1589-1589. DOI: 10.1182/Blood.V116.21.1589.1589 |
0.829 |
|
| 2010 |
Kerr CL, Cheng L. Multiple, interconvertible states of human pluripotent stem cells (Cell Stem Cell (2010) 6 (497-499)) Cell Stem Cell. 7. DOI: 10.1016/J.Stem.2010.07.009 |
0.571 |
|
| 2009 |
Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood. 114: 5473-5480. PMID 19797525 DOI: 10.1182/Blood-2009-04-217406 |
0.841 |
|
| 2009 |
Cheng L. Better positioned in stem cells. Blood. 114: 1285-6. PMID 19679697 DOI: 10.1182/Blood-2009-05-221754 |
0.598 |
|
| 2009 |
Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell. 5: 97-110. PMID 19540188 DOI: 10.1016/J.Stem.2009.05.023 |
0.814 |
|
| 2009 |
Pomper MG, Hammond H, Yu X, Ye Z, Foss CA, Lin DD, Fox JJ, Cheng L. Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models. Cell Research. 19: 370-9. PMID 19114988 DOI: 10.1038/Cr.2008.329 |
0.708 |
|
| 2009 |
Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ, Maccallum J. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Head & Neck. 31: 94-101. PMID 18853445 DOI: 10.1002/Hed.20935 |
0.412 |
|
| 2009 |
Durai M, Krueger C, Ye Z, Cheng L, Mackensen A, Oelke M, Schneck JP. In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC). Cancer Immunology, Immunotherapy : Cii. 58: 209-20. PMID 18563409 DOI: 10.1007/S00262-008-0542-1 |
0.653 |
|
| 2009 |
Ye Z, Zhan H, Mali P, Dowey S, Williams D, Jang Y, Van Dang C, Spivak JL, Moliterno AR, Cheng L. Hematopoiesis of Human Induced Pluripotent Stem Cells Derived From Blood Cells of Healthy Donors and Patients with the JAK2-V617F Somatic Mutation. Blood. 114: 812-812. DOI: 10.1182/Blood.V114.22.812.812 |
0.842 |
|
| 2008 |
Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, Bae J, Cheng L, Elisseeff J. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 20641-6. PMID 19095799 DOI: 10.1073/Pnas.0809680106 |
0.743 |
|
| 2008 |
Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, Belton A, Turkson J, Jaganathan S, Cheng L, Ye Z, Jove R, Aplan P, Lin YW, Wertzler K, Reeves R, et al. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Research. 68: 10121-7. PMID 19074878 DOI: 10.1158/0008-5472.Can-08-2121 |
0.689 |
|
| 2008 |
Wu Z, Zhang W, Chen G, Cheng L, Liao J, Jia N, Gao Y, Dai H, Yuan J, Cheng L, Xiao L. Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells. The Journal of Biological Chemistry. 283: 24991-5002. PMID 18596037 DOI: 10.1074/Jbc.M803893200 |
0.502 |
|
| 2008 |
Mali P, Ye Z, Hommond HH, Yu X, Lin J, Chen G, Zou J, Cheng L. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells (Dayton, Ohio). 26: 1998-2005. PMID 18511599 DOI: 10.1634/Stemcells.2008-0346 |
0.835 |
|
| 2008 |
Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A, Mali P, Li YM, Civin C, Gaiano N, Cheng L. Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell. 2: 461-71. PMID 18462696 DOI: 10.1016/J.Stem.2008.03.001 |
0.799 |
|
| 2008 |
Chen G, Ye Z, Yu X, Zou J, Mali P, Brodsky RA, Cheng L. Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins. Cell Stem Cell. 2: 345-55. PMID 18397754 DOI: 10.1016/J.Stem.2008.02.004 |
0.817 |
|
| 2008 |
Cheng L, Xiao L, Zeng F, Zhang YA. Stem cells shine in Shanghai. Cell Stem Cell. 2: 34-7. PMID 18371419 DOI: 10.1016/J.Stem.2007.12.010 |
0.377 |
|
| 2008 |
Ye Z, Yu X, Cheng L. Lentiviral gene transduction of mouse and human stem cells. Methods in Molecular Biology (Clifton, N.J.). 430: 243-53. PMID 18370304 DOI: 10.1007/978-1-59745-182-6_17 |
0.775 |
|
| 2008 |
Cheng L. More new lines of human parthenogenetic embryonic stem cells Cell Research. 18: 215-217. PMID 18246085 DOI: 10.1038/Cr.2008.19 |
0.532 |
|
| 2008 |
Resar L, Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, Belton A, Turkson J, Jaganathan S, Cheng L, Ye Z, Lin Y, Aplan PD, Jove R, Kowalski J, et al. The HMGA1a-STAT3 axis: an “Achilles Heel” for Hematopoietic Malignancies Overexpressing HMGA1a? Blood. 112: 3810-3810. DOI: 10.1182/Blood.V112.11.3810.3810 |
0.712 |
|
| 2008 |
Ye Z, Yu X, Cheng L. Efficient Production of Human Hematopoietic Progenitors from Human Pluripotent Stem Cells Using Chemically Defined Media without Serum or Feeder Cells Blood. 112: 2463-2463. DOI: 10.1182/Blood.V112.11.2463.2463 |
0.771 |
|
| 2008 |
Savage WJ, Barber J, Cheng L, Chen G, Thoburn C, Hu R, Mukhina G, Matsui W, Hess A, Jones R, Brodsky RA. GPI-Anchored Protein Deficiency Confers Resistance to Apoptosis in PNH. Blood. 112: 2035-2035. DOI: 10.1182/Blood.V112.11.2035.2035 |
0.429 |
|
| 2008 |
Cheng L. Human embryonic stem cells as a research model for human biology and diseases Cell Research. 18. DOI: 10.1038/Cr.2008.98 |
0.615 |
|
| 2007 |
Baba S, Cho SY, Ye Z, Cheng L, Engles JM, Wahl RL. How reproducible is bioluminescent imaging of tumor cell growth? Single time point versus the dynamic measurement approach. Molecular Imaging. 6: 315-22. PMID 18092516 DOI: 10.2310/7290.2007.00031 |
0.601 |
|
| 2007 |
Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 12: 230-8. PMID 17785204 DOI: 10.1016/J.Ccr.2007.08.004 |
0.304 |
|
| 2007 |
Li L, Piloto O, Kim KT, Ye Z, Nguyen HB, Yu X, Levis M, Cheng L, Small D. FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells. British Journal of Haematology. 137: 64-75. PMID 17359372 DOI: 10.1111/J.1365-2141.2007.06525.X |
0.775 |
|
| 2007 |
Zhou L, Wei X, Cheng L, Tian J, Jiang JJ. CD133, one of the markers of cancer stem cells in Hep-2 cell line. The Laryngoscope. 117: 455-60. PMID 17334305 DOI: 10.1097/01.Mlg.0000251586.15299.35 |
0.429 |
|
| 2007 |
Cai L, Ye Z, Zhou BY, Mali P, Zhou C, Cheng L. Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Research. 17: 62-72. PMID 17211448 DOI: 10.1038/Sj.Cr.7310138 |
0.834 |
|
| 2007 |
Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genetics. 39: 237-42. PMID 17211412 DOI: 10.1038/Ng1972 |
0.482 |
|
| 2007 |
Zhou BY, Ye Z, Chen G, Gao ZP, Zhang YA, Cheng L. Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer. Stem Cells (Dayton, Ohio). 25: 779-89. PMID 17158240 DOI: 10.1634/Stemcells.2006-0128 |
0.748 |
|
| 2006 |
Dravid G, Hammond H, Cheng L. Culture of human embryonic stem cells on human and mouse feeder cells. Methods in Molecular Biology (Clifton, N.J.). 331: 91-104. PMID 16881511 DOI: 10.1385/1-59745-046-4:91 |
0.585 |
|
| 2006 |
Cheng L, Qiu RZ, Deng H, Zhang YA, Jin Y, Li L. Ethics: China already has clear stem-cell guidelines. Nature. 440: 992. PMID 16625175 DOI: 10.1038/440992B |
0.507 |
|
| 2006 |
Yu X, Alder JK, Chun JH, Friedman AD, Heimfeld S, Cheng L, Civin CI. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells (Dayton, Ohio). 24: 876-88. PMID 16513761 DOI: 10.1634/Stemcells.2005-0598 |
0.555 |
|
| 2006 |
Mali P, Cheng L. Reprogramming somatic cells without fusion or ethical confusion Regenerative Medicine. 1: 837-840. DOI: 10.2217/17460751.1.6.837 |
0.77 |
|
| 2006 |
Chen G, Ye Z, Yu X, Brodsky RA, Cheng L. Developmental Potentials of Human Embryonic Stem Cells Lacking PIG-A and GPI-Anchored Proteins. Blood. 108: 1314-1314. DOI: 10.1182/Blood.V108.11.1314.1314 |
0.778 |
|
| 2006 |
Zhou BY, Ye Z, Gao P, Cheng L. 100. Inducible and Reversible Transgene Expression in Human Stem Cells Stably Transduced by Novel Lentiviral Vectors Molecular Therapy. 13: S41. DOI: 10.1016/J.Ymthe.2006.08.119 |
0.763 |
|
| 2005 |
Wang K, Xue T, Tsang SY, Van Huizen R, Wong CW, Lai KW, Ye Z, Cheng L, Au KW, Zhang J, Li GR, Lau CP, Tse HF, Li RA. Electrophysiological properties of pluripotent human and mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 23: 1526-34. PMID 16091557 DOI: 10.1634/Stemcells.2004-0299 |
0.677 |
|
| 2005 |
Dravid G, Ye Z, Hammond H, Chen G, Pyle A, Donovan P, Yu X, Cheng L. Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells (Dayton, Ohio). 23: 1489-501. PMID 16002782 DOI: 10.1634/Stemcells.2005-0034 |
0.712 |
|
| 2005 |
Chou WC, Chen HY, Yu SL, Cheng L, Yang PC, Dang CV. Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 106: 304-10. PMID 15761015 DOI: 10.1182/Blood-2005-01-0241 |
0.339 |
|
| 2004 |
Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, Gearhart J, Cheng L. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet (London, England). 364: 163-71. PMID 15246729 DOI: 10.1016/S0140-6736(04)16629-4 |
0.731 |
|
| 2004 |
Dunlap S, Yu X, Cheng L, Civin CI, Alani RM. High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. The Journal of Investigative Dermatology. 122: 549-51. PMID 15009744 DOI: 10.1046/J.0022-202X.2004.22214.X |
0.378 |
|
| 2004 |
Pan F, Ye Z, Cheng L, Liu JO. Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT). The Journal of Biological Chemistry. 279: 14477-80. PMID 14722108 DOI: 10.1074/Jbc.C300487200 |
0.633 |
|
| 2004 |
Li L, Piloto O, Kim K, Ye Z, Nguyen B, Yu X, Levis M, Cheng L, Small D. FLT3/ITD Expression Increases Expansion, Survival and Entry into Cell Cycle of Human Hematopoietic Stem Cells. Blood. 104: 484-484. DOI: 10.1182/Blood.V104.11.484.484 |
0.765 |
|
| 2003 |
Ye Z, Cheng L. Making lentiviral vectors more powerful and universal. Discovery Medicine. 3: 48-9. PMID 20704865 |
0.71 |
|
| 2003 |
Zhou X, Cui Y, Huang X, Yu Z, Thomas AM, Ye Z, Pardoll DM, Jaffee EM, Cheng L. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells. Human Gene Therapy. 14: 1089-105. PMID 12885348 DOI: 10.1089/104303403322124800 |
0.707 |
|
| 2003 |
Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z, Peng T, Malehorn MT, Yang X, Civin CI, Cheng L. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 827-38. PMID 12788657 DOI: 10.1016/S1525-0016(03)00104-7 |
0.732 |
|
| 2003 |
Cui Y, Kelleher E, Straley E, Fuchs E, Gorski K, Levitsky H, Borrello I, Civin CI, Schoenberger SP, Cheng L, Pardoll DM, Whartenby KA. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells. Nature Medicine. 9: 952-8. PMID 12778137 DOI: 10.1038/Nm882 |
0.411 |
|
| 2003 |
Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, Krause DS. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Experimental Hematology. 31: 413-20. PMID 12763140 DOI: 10.1016/S0301-472X(03)00042-0 |
0.542 |
|
| 2003 |
McCauslin CS, Wine J, Cheng L, Klarmann KD, Candotti F, Clausen PA, Spence SE, Keller JR. In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals Blood. 102: 843-848. PMID 12689938 DOI: 10.1182/blood-2002-12-3859 |
0.409 |
|
| 2003 |
Cheng L, Hammond H, Ye Z, Zhan X, Dravid G. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells (Dayton, Ohio). 21: 131-42. PMID 12634409 DOI: 10.1634/Stemcells.21-2-131 |
0.768 |
|
| 2002 |
Whartenby KA, Straley EE, Kim H, Racke F, Tanavde V, Gorski KS, Cheng L, Pardoll DM, Civin CI. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood. 100: 3147-54. PMID 12384412 DOI: 10.1182/Blood-2002-01-0118 |
0.462 |
|
| 2002 |
De Miguel MP, Cheng L, Holland EC, Federspiel MJ, Donovan PJ. Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer Proceedings of the National Academy of Sciences of the United States of America. 99: 10458-10463. PMID 12140361 DOI: 10.1073/Pnas.122249399 |
0.45 |
|
| 2002 |
Cui Y, Golob J, Kelleher E, Ye Z, Pardoll D, Cheng L. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells. Blood. 99: 399-408. PMID 11781219 DOI: 10.1182/Blood.V99.2.399 |
0.768 |
|
| 2001 |
Gao Z, Golob J, Tanavde VM, Civin CI, Hawley RG, Cheng L. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells (Dayton, Ohio). 19: 247-59. PMID 11359950 DOI: 10.1634/Stemcells.19-3-247 |
0.544 |
|
| 2001 |
Yang X, Liu H, Li D, Zhou X, Jung WC, Deans AE, Cui Y, Cheng L. Digital optical imaging of green fluorescent proteins for tracking vascular gene expression: feasibility study in rabbit and human cell models. Radiology. 219: 171-5. PMID 11274553 DOI: 10.1148/Radiology.219.1.R01Ap23171 |
0.347 |
|
| 2001 |
Shamblott MJ, Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro Proceedings of the National Academy of Sciences. 98: 113-118. DOI: 10.1073/Pnas.98.1.113 |
0.597 |
|
| 2000 |
Liu X, Rapp N, Deans R, Cheng L. Molecular cloning and chromosomal mapping of a candidate cytokine gene selectively expressed in human CD34+ cells. Genomics. 65: 283-292. PMID 10857752 DOI: 10.1006/Geno.2000.6170 |
0.426 |
|
| 2000 |
Novelli EM, Cheng L, Yang Y, Leung W, Ramírez M, Tanavde V, Enger C, Civin CI. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency. Human Gene Therapy. 10: 2927-40. PMID 10609654 DOI: 10.1089/10430349950016348 |
0.541 |
|
| 2000 |
Liu X, Rapp N, Deans R, Cheng L. A candidate cytokine gene selectively expressed in human CD34+ cells Experimental Hematology. 28: 63. DOI: 10.1016/S0301-472X(00)00284-8 |
0.437 |
|
| 2000 |
Cui Y, Golob J, Huang X, Pardoll D, Cheng L. Specific transgene expression in antigen presenting cells derived from lentivirally transduced hematopoietic stem/progenitor cells Experimental Hematology. 28: 62-63. DOI: 10.1016/S0301-472X(00)00283-6 |
0.514 |
|
| 1998 |
Donovan PJ, de Miguel M, Cheng L, Resnick JL. Primordial germ cells, stem cells and testicular cancer. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 106: 134-41. PMID 9524571 DOI: 10.1111/J.1699-0463.1998.Tb01328.X |
0.509 |
|
| 1998 |
Cheng L, Du C, Lavau C, Chen S, Tong J, Chen BP, Scollay R, Hawley RG, Hill B. Sustained Gene Expression in Retrovirally Transduced, Engrafting Human Hematopoietic Stem Cells and Their Lympho-Myeloid Progeny Blood. 92: 83-92. DOI: 10.1182/Blood.V92.1.83.413K09_83_92 |
0.597 |
|
| 1997 |
Cheng L, Du C, Murray D, Tong X, Zhang YA, Chen BP, Hawley RG. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells Gene Therapy. 4: 1013-1022. PMID 9415306 DOI: 10.1038/Sj.Gt.3300507 |
0.572 |
|
| 1996 |
Cheng L, Fu J, Tsukamoto A, Hawley RG. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells Nature Biotechnology. 14: 606-609. PMID 9630951 DOI: 10.1038/Nbt0596-606 |
0.402 |
|
| 1996 |
Yang TT, Cheng L, Kain SR. Optimized Codon Usage and Chromophore Mutations Provide Enhanced Sensitivity with the Green Fluorescent Protein Nucleic Acids Research. 24: 4592-4593. PMID 8948654 DOI: 10.1093/Nar/24.22.4592 |
0.302 |
|
| 1992 |
Resnick JL, Bixler LS, Cheng L, Donovan PJ. Long-term proliferation of mouse primordial germ cells in culture Nature. 359: 550-551. PMID 1383830 DOI: 10.1038/359550A0 |
0.505 |
|
| Show low-probability matches. |